Ciprofloxacin And Dexamethasone Suspension/ Drops
Product Images NDC 53746-831

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin And Dexamethasone (NDC 53746-831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure 1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 1)

Chemical structure diagram of Ciprofloxacin, showing its molecular arrangement including rings, nitrogen, fluorine, and hydroxyl groups along with hydrochloride and water of hydration (HCl•H2O).*

FDA Label Image

Structure 2 (Ciprofloxacin And Dexamethasone Otic Suspension Us 2)

Chemical structure of Ciprofloxacin and Dexamethasone, illustrating the molecular framework with labeled atoms including oxygen, hydrogen, fluorine, and carbon positions.*

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 3)

An instructional illustration showing two hands being washed under running water, demonstrating proper handwashing technique.*

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 4)

An instructional illustration showing a person holding a small bottle of ear drops. The illustration demonstrates holding the bottle in one hand while using the other hand to support or steady it, indicating preparation for administering otic suspension drops.*

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 5)

An instructional illustration showing a person lying on their side with the head tilted to expose the ear, likely demonstrating the proper positioning for administering otic suspension or drops.*

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 6)

An instructional illustration showing the administration of ear drops. A hand is holding a dropper bottle and dispensing drops into an ear canal.*

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 7)

An instructional diagram showing three steps for administering Ciprofloxacin and Dexamethasone otic suspension/drops. The images depict hand positioning and ear manipulation: pulling the ear upward, backward, and then the proper angle for dropper insertion into the ear canal.*

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 8)

Label for Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP, a sterile ear drop suspension. The label displays NDC 53746-831, volume of 7.5 mL, and states it is for auricular use only. It includes active ingredient strengths and instructions to store at 20° to 25°C, shake well before use, and avoid freezing. Manufactured by Amneal Pharmaceuticals of New York LLC, made in India.*

FDA Label Image

2 (Ciprofloxacin And Dexamethasone Otic Suspension Us 9)

Label for Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension USP, 7.5 mL bottle, indicated for auricular use. The label shows active and inactive ingredients, storage instructions, and manufacturer info: Amneal Pharmaceuticals of New York LLC. The product is sterile and Rx only. It includes warnings to shake well before using and to use for ears only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.